Study of Gemcitabine + PEGPH20 vs Gemcitabine Alone in Stage IV Previously Untreated Pancreatic Cancer
Clinical trial NCT01453153 · COMPLETED
Trial details
- NCT number
- NCT01453153
- Sponsor
- Halozyme Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2014-02-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.